OGEN ORAGENICS INC Delisting Actions 8-K Filing 2024 - Delisting Notice Oragenics, Inc. received a notice from NYSE American for failing to meet listing standards due to insufficient stockholders' equity of less than $2 million, while also announcing progress on its drug candidate ONP-002 for treating concussions.Get access to all SEC 8-K filings of the ORAGENICS INC